Skip to main content
Equibles

4565 · Nxera Pharma Co., Ltd. · Financials

Use 4565 with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research 4565.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
1,788 JPY -23 (-1.27%) At close · Nov 12
Rebalance outlook locked
Market Cap
163.38B JPY
Shares
91.38M
Volume · Nov 12 1.64M Avg daily vol (3M) 1.49M

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Pull these statements through the financial statements API or MCP →
Revenue
29.62B +2.7%
FY2025 Revenue FY2021–FY2025
Net Income
-12.53B -159%
FY2025 Net Income FY2021–FY2025
Gross Margin
72.32% -1.3pp
FY2025 Gross Margin FY2021–FY2025
Operating Margin
-28.57% -9.8pp
FY2025 Operating Margin FY2021–FY2025
Operating Cash Flow
-2.67B +65.4%
FY2025 Operating Cash Flow FY2021–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow All Metrics
Annual Quarterly
Line Item FY2025 FY2024 FY2023 FY2022 FY2021
JPY 29.62B 28.84B 12.77B 15.57B 17.71B
JPY 8.2B 7.62B 3.1B 926M 933M
JPY 21.42B 21.22B 9.66B 14.64B 16.78B
JPY -8.46B -5.42B -9.53B 3.44B 3.78B
JPY -14.95B -4.66B -10.68B 1.08B 433M
JPY -2.42B 176M -3.49B 696M -584M
JPY -12.53B -4.84B -7.19B 382M 1.02B
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Debt Profile

No verified debt profile is available yet. This does not establish that the company has no debt or covenants.